As marijuana tourism flourishes, out-of-town stoners are looking for places to legally light up. Cannabis Culture's Jodie Emery joins Cheddar to discuss Ontario's new proposal to permit marijuana consumption in hotels when the country legalizes cannabis this summer. She explains how the legalization movement is forcing countries to reconsider their tourism policies. Also, a California Girl Scout sold 300 boxes of cookies outside a marijuana dispensary. Emery reveals how plenty of entrepreneurial types are benefiting from trends in legalization. The San Diego Girl Scout Council is weighing whether the girl broke any rules. Baker is a new e-commerce platform being rolled out to dispensaries to improve their business logistics. Emery explains what products like this mean for the proliferation of the marijuana business services industry. The API has 25 integrations to allow for better point-of-sale systems.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More